The exercise period for Series TO 1 B of Calmark's subscription warrants begins today

Today, 23 May 2019, marks the beginning of the exercise period for the Series TO 1 B subscription warrants that were issued in connection with Calmark Sweden AB (publ)’s ("Calmark") spring/summer 2018 issue of units prior to listing. The exercise period runs until and including 13 June 2019. Holders of subscription warrants for Series TO 1 B are entitled, for each warrant, to subscribe for one new B share in the company at a price of SEK 5.40 per share. On full exercise of all Series TO 1 B subscription warrants, Calmark will raise approximately MSEK 16.2 before issuance costs.

Summary of the terms for the subscription warrants

  • Exercise period: 23 May – 13 June 2019.
  • Subscription price: SEK 5.40 per B share.
  • Issuance volume: There are 3,000,000 subscription warrants in series TO 1 B outstanding. On full exercise of all Series TO 1 B subscription warrants, Calmark will raise approximately MSEK 16.2 before issuance costs.
  • The last day of trading of subscription warrants: 11 June 2019.
  • Number of outstanding shares of Calmark: 10,404,500 shares.
  • Pre-money valuation: Approximately MSEK 56.1.
  • Market value as of 2019-05-22: Approximately MSEK 66.1.

Teaser and application form is available on the Calmark website (www.calmark.se). Teaser and application form is also available at the websites of Sedermera Fondkommission (www.sedermera.se) and Spotlight Stock Market (www.spotlightstockmarket.com), respectively. Complete conditions for Series TO 1 B subscription warrants are available in the Calmark prospectus published in May 2018. The prospectus is available from the websites above.

Important dates for the exercise period for Series TO 1 subscription warrants

  • Exercise period begins: 23 May 2019.
  • The last day of trading of subscription warrants: 11 June 2019.
  • Exercise period ends: 13 June 2019.
  • Payment: Simultaneous cash payment no later than 15.00 on 13 June 2019.
  • Planned communication of outcomes: Week 25.
  • Intended conversion of the interim shares to B shares: Week 28.

Investor meetings

In connection with the exercise period, Calmark’s representatives will attend Småbolagsjakten Live on 28 May 2019 to inform about the operations and future plans of the company. The Investerarträffen event is free of charge and registration is available via investerarbrevet.se. Småbolagsjakten Live is broadcasted live in the Facebook group Småbolagsjakten, on the Nyhetsbyrån Direkt YouTube channel, and on Investerarbrevet.se.

Location: GT30, Bond, Grev Turegatan 30, Stockholm.
Time: 19:50

Financial advisor

Sedermera Fondkommission is the financial advisor and issuing agent of Calmark in connection with the exercise period for the company’s Series TO 1 B subscription warrants.

For more information regarding the subscription of Series TO 1 B subscription warrants, please contact:

Sedermera Fondkommission
Telephone: +46 40-615 14 10
E-mail: info@sedermera.se

For more information about Calmark Sweden AB, please contact:

Anna Söderlund, CEO
Telefon: +46 70 213 25 35

E-post: anna.soderlund@calmark.se 
www.calmark.se 

Calmark Sweden AB is a medical technology company developing a point-of-care (POC) analyzis method with easier and faster sampling of medical conditions in newborns. The unique test platform, which consists of a reader and single-use products, is expected to be ready for launch in 2020 when three important POC tests are introduced. The WHO estimates that 1.5 billion children will be born worldwide by 2030. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter healthcare chains. In less developed healthcare systems, the product helps save lives. Calmark aims to become the global leader and ultimately to offer all relevant POC tests for the first period of life, regardless of where in the world a baby is born. Read more about Calmark www.calmark.se/eng/home.  

Tags: